Taysha Gene Therapies, Inc. TSHA Debt Issuance Costs
Debt Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 15, 2025, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s debt issuance costs?
- Taysha Gene Therapies, Inc. (TSHA) reported debt issuance costs of $18K in Q1 2024.
- How has Taysha Gene Therapies, Inc.'s debt issuance costs changed year-over-year?
- Taysha Gene Therapies, Inc.'s debt issuance costs decreased by 82.0% year-over-year, from $99.75K to $18K.
- What does debt issuance costs mean?
- Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.